Published in Clin Geriatr Med on May 01, 1986
Stem cells and repair of lung injuries. Respir Res (2004) 0.96
Hypoxia-induced angiogenesis is delayed in aging mouse brain. Brain Res (2011) 0.89
Analysis of the influential factors of maximal-effort expiratory capacity of elderly women. J Phys Ther Sci (2016) 0.75
Physiological responses to interval endurance exercise at different levels of blood flow restriction. Eur J Appl Physiol (2016) 0.75
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest (1984) 5.19
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J (2002) 4.68
Risk and incidence of asthma attributable to occupational exposure among HMO members. Am J Ind Med (1998) 2.07
Salmeterol plus theophylline combination therapy in the treatment of COPD. Chest (2001) 2.01
Minimal important difference of the transition dyspnoea index in a multinational clinical trial. Eur Respir J (2003) 1.84
Dyspnea ratings for prescription of cross-modal exercise in patients with COPD. Chest (1998) 1.54
Assessment of cardiac performance with quantitative radionuclide angiocardiography: right ventricular ejection fraction with reference to findings in chronic obstructive pulmonary disease. Am J Cardiol (1978) 1.37
Clinical and roentgenographic features of nosocomial pulmonary disease due to Mycobacterium xenopi. Am Rev Respir Dis (1981) 1.32
Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway disease. Am Rev Respir Dis (1985) 1.30
Diaphragmatic dysfunction in siblings with hereditary motor and sensory neuropathy (Charcot-Marie-Tooth disease). Chest (1987) 1.22
Acute and chronic effects of fire fighting on pulmonary function. Chest (1980) 1.08
Respiratory muscle fatigue after marathon running. J Appl Physiol Respir Environ Exerc Physiol (1982) 1.08
Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD. Respir Med (2009) 1.07
Targeted inspiratory muscle training improves respiratory muscle function and reduces dyspnea in patients with chronic obstructive pulmonary disease. Ann Intern Med (1989) 1.06
Air-fluid levels within lung bullae associated with pneumonitis. Lung (1981) 1.03
Rabbit lung after acute smoke inhalation. Cellular responses and scanning electron microscopy. Arch Surg (1984) 1.02
Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment. Arch Gen Psychiatry (1986) 1.02
Comparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive airway disease. Am Rev Respir Dis (1987) 1.01
Peri-emphysematous lung infection. Clin Chest Med (1981) 0.98
Descriptors of breathlessness in healthy individuals: distinct and separable constructs. Chest (2000) 0.97
Exercise impairment in chronic obstructive pulmonary disease. Clin Chest Med (1984) 0.95
Bilateral diaphragmatic paralysis: clinical spectrum, prognosis, and diagnostic approach. Arch Phys Med Rehabil (1988) 0.92
Dyspnea ratings for prescribing exercise intensity in patients with COPD. Chest (1996) 0.92
Physiologic changes in rowing performance associated with training in collegiate women rowers. Int J Sports Med (1985) 0.91
Right and left ventricular exercise performance in chronic obstructive pulmonary disease: radionuclide assessment. Ann Intern Med (1980) 0.91
Effect of physical training on exercise performance of children following surgical repair of congenital heart disease. Pediatrics (1981) 0.90
Influence of exercise on urea, creatinine, and 3-methylhistidine excretion in normal human subjects. Am J Physiol (1984) 0.90
Right ventricular performance and central circulatory hemodynamics during upright exercise in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis (1984) 0.88
Progressive immune failure in dyskeratosis congenita. Report of an adult in whom Pneumocystis carinii and fatal disseminated candidiasis developed. Arch Intern Med (1984) 0.88
Target dyspnea ratings predict expected oxygen consumption as well as target heart rate values. Am J Respir Crit Care Med (1999) 0.87
Comparison of 6-min "all-out" and incremental exercise tests in elite oarsmen. Med Sci Sports Exerc (1984) 0.86
Radiographic manifestations of acute smoke inhalation. AJR Am J Roentgenol (1977) 0.85
Effects of aminophylline upon right and left ventricular performance in chronic obstructive pulmonary disease: noninvasive assessment by radionuclide angiocardiography. Am J Med (1978) 0.85
Volumetric responses of right and left ventricles during upright exercise in normal subjects. J Appl Physiol (1985) (1985) 0.85
Salmeterol reduces dyspnea and improves lung function in patients with COPD. Chest (1997) 0.85
Improvement in cardiac performance by oral long-acting theophylline in chronic obstructive pulmonary disease. Am Heart J (1982) 0.85
Mechanical and physiological evaluation of exercise performance in elite national rowers. JAMA (1984) 0.85
The pulmonary effects of free-base cocaine: a review. Cleve Clin J Med (1993) 0.84
Acute effects of passive smoking on lung function and airway reactivity in asthmatic subjects. Chest (1986) 0.84
Intratumoral Bacillus Calmette-Guérin immunotherapy prior to surgery for carcinoma of the lung: results of a prospective randomized trial. Cancer Res (1986) 0.84
Pathophysiology of dyspnea. Monaldi Arch Chest Dis (2001) 0.83
Techniques for diagnosing lung cancer. A critical review. Clin Chest Med (1982) 0.83
The frequency of workplace exacerbation among health maintenance organisation members with asthma. Occup Environ Med (2006) 0.83
Helium-oxygen flow-volume curves in detecting acute response to hair spray. Int Arch Occup Environ Health (1981) 0.83
Ventilatory responses at rest and during exercise in marathon runners. J Appl Physiol Respir Environ Exerc Physiol (1982) 0.82
Right and left ventricular performance in ambulatory young adults with cystic fibrosis. Br Heart J (1980) 0.82
Aging and exercise performance. Clin Geriatr Med (1986) 0.81
Dyspnea: mechanisms, evaluation and treatment. Am Rev Respir Dis (1988) 0.81
Normal arterial oxygen saturation with the ear oximeter in patients with leukemia and leukocytosis. Cancer (1984) 0.81
Lung function after marathon running at warm and cold ambient temperatures. Am Rev Respir Dis (1981) 0.80
Comparison of dyspnea ratings during submaximal constant work exercise with incremental testing. Med Sci Sports Exerc (1998) 0.80
Does entrained breathing improve the economy of rowing? Med Sci Sports Exerc (1994) 0.80
Relationship between oxygen uptake and oxygen transport in stable patients with chronic obstructive pulmonary disease. Physiologic effects of nitroprusside and hydralazine. Am Rev Respir Dis (1984) 0.79
Exercise testing in occupational lung diseases. Clin Chest Med (1984) 0.79
Recurrent left pleural effusion in a 44-year-old woman with a history of alcohol abuse. Chest (1996) 0.79
Do you speak the language of dyspnea? Chest (2000) 0.79
Effectiveness of salmeterol versus ipratropium bromide on exertional dyspnoea in COPD. Eur Respir J (2001) 0.78
Right ventricular function at rest and during exercise in chronic obstructive pulmonary disease. Chest (1992) 0.78
Evaluation of dyspnea in the elderly patient. Clin Chest Med (1993) 0.78
Pulmonary function in runners before and after a 20 kilometer road race. Conn Med (1980) 0.78
Dyspnea: diagnosis and management. Clin Chest Med (1987) 0.78
Administration of a perfluorochemical emulsion plus carbogen breathing does not alter radiation pneumonitis. Proc Soc Exp Biol Med (1995) 0.78
The role of theophylline in the treatment of dyspnea in COPD. Chest (1987) 0.77
Systemic and discoid lupus erythematosus: analysis of pulmonary function. Yale J Biol Med (1978) 0.77
Determination of cardiac output at rest and during exercise by carbon dioxide rebreathing method in obstructive airway disease. Am Rev Respir Dis (1985) 0.76
Timing of oral anticoagulation therapy in the treatment of angiographically proven acute pulmonary embolism. Arch Intern Med (1987) 0.76
Cardiovascular responses to rowing. Med Sci Sports Exerc (1987) 0.75
Pulmonary dysfunction in ultramarathon runners. Yale J Biol Med (1982) 0.75
Use of the breathing reserve to interpret submaximal exercise responses. Chest (1998) 0.75
Terbutaline and diaphragm function in chronic obstructive pulmonary disease: a double-blind randomized clinical trial. Br J Dis Chest (1988) 0.75
Detection of microscopic particles present as contaminants in latent fingerprints by means of synchrotron radiation-based Fourier transform infra-red micro-imaging. Analyst (2012) 0.75
Rabies in Delaware. Del Med J (1974) 0.75
Anticholinergic poisoning from Jimson weed. JACEP (1976) 0.75
Spectroscopic detection of exogenous materials in latent fingerprints treated with powders and lifted off with adhesive tapes. Anal Bioanal Chem (2014) 0.75
Cost of anaesthesia. Can J Anaesth (1993) 0.75
Characterisation of asthma management in the Fallon Community Health Plan from 1988 to 1991. Pharmacoeconomics (1996) 0.75
Carboxyhemoglobin levels in fire fighters. Lung (1976) 0.75
The Physiology of Marathon Running. Phys Sportsmed (1985) 0.75
Put an end to Steinman pin sharps injuries. Ann R Coll Surg Engl (2008) 0.75
Looped bronchoscope. Chest (1978) 0.75
Letter: The Jimson-weed high. JAMA (1975) 0.75
The Migrant Health Clinic in Dover. Del Med J (1975) 0.75
Letter: Jimson weed seeds. Ann Intern Med (1975) 0.75